Abrorjon Yusupbekov

4 ta ish

National Cancer Center of Uzbekistan, Tashkent, Uzbekistan;

1. Complex approach in the treatment of retroperitoneal fibrosarcoma.

   Firdavs Ulmasov, M. Djuraev, Abrorjon Yusupbekov +1

   MaqolaSarcoma Diagnosis and TreatmentJournal of Clinical Oncology20170 iqtibos

   ABIABI:AkademIndex/openalex/2017.article.000940

2. Exacerbated prognostic impact of multiple intramural metastasis versus single intramural metastasis of thoracic esophageal squamous cell carcinoma: evidence from an Uzbekistan cohort

   Abrorjon Yusupbekov, Takahiro Shinozuka, E.E. Juraev +4

   MaqolaEsophageal Cancer Research and TreatmentSurgery Today20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.004426

3. The outcomes of atezolizumab therapy in combination with carboplatin and etoposide for small-cell lung cancer.

   Sergey Kamishov, Mirzagaleb Tillyashaykhov, Abrorjon Yusupbekov +6

   MaqolaLung Cancer Research StudiesJournal of Clinical Oncology20240 iqtibos

   ABIABI:AkademIndex/openalex/2024.article.006753

4. Clarithromycin Resistance and Treatment Outcomes in <i>Helicobacter pylori</i> Infections: Molecular Genetic Study From Uzbekistan

   J. A. Ismailova, Abrorjon Yusupbekov, Abrorjon Abdurakhimov +1

   MaqolaHelicobacter pylori-related gastroenterology studiesGastroenterology Research and Practice20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.007346